Table 4 HRs (95% CI) of quartiles of TG/HDL-C for incident prediabetes^† and T2DM^†† among men

Normoglycemia^††† to incident prediabetes

TG/HDL-C < 1.09

1.09 ≤ TG/HDL-C < 1.69

1.69 ≤ TG/HDL-C < 2.65

TG/HDL-C ≥ 2.65

(E/N = 219/565)

(E/N = 269/559)

(E/N = 280/564)

(E/N = 302/559)

Model 1

Reference

1.32 (1.11–1.58)

1.40 (1.17–1.67)

1.50 (1.26–1.78)

 < 0.001

Model 2

Reference

1.25 (1.04–1.49)

1.22 (1.02–1.46)

1.29 (1.07–1.54)

0.01

Model 3

Reference

1.25 (1.05–1.50)

1.20 (1.00–1.43)

1.23 (1.03–1.47)

0.06

Normoglycemia to incident T2DM

TG/HDL-C < 1.09

1.09 ≤ TG/HDL-C < 1.69

1.69 ≤ TG/HDL-C < 2.65

TG/HDL-C ≥ 2.65

(E/N = 23/565)

(E/N = 32/559)

(E/N = 44/564)

(E/N = 59/559)

Model 1

Reference

1.38 (0.81–2.35)

1.89 (1.14–3.14)

2.53 (1.56–4.10)

 < 0.001

Model 2

Reference

1.26 (0.73–2.15)

1.42 (0.85–2.38)

1.84 (1.12–3.01)

0.01

Model 3

Reference

1.26 (0.74–2.17)

1.41 (0.84–2.35)

1.76 (1.07–2.89)

0.02

Prediabetes to incident T2DM

TG/HDL-C < 1.35

1.35 ≤ TG/HDL-C < 2.17

2.17 ≤ TG/HDL-C < 3.42

TG/HDL-C ≥ 3.42

(E/N = 54/162)

(E/N = 62/162)

(E/N = 63/162)

(E/N = 73/161)

Model 1

Reference

1.25 (0.87–1.80)

1.25 (0.87–1.79)

1.50 (1.05–2.13)

0.03

Model 2

Reference

1.22 (0.84–1.76)

1.03 (0.70–1.52)

1.32 (0.91–1.91)

0.24

Model 3

Reference

1.29 (0.89–1.87)

1.14 (0.77–1.69)

1.41 (0.97–2.04)

0.12